Table 3.

Dissemination phase site engagement activities for multi-site clinical trials.

Activity	Study Role Target	Conventional Approach	Novel Approach	Evaluation Criteria
Presentations and Publications	•Executive committee •Regulatory committee •Physics committee •Advocacy partners •Stakeholders •Site PIs •CRCs	Physician preparation of conference posters and presentations at large academic and medical conferences	Site team representatives and advocacy partners present at advocacy and local community organization conferences	•Number of paper and poster submissions •Number of acceptances •Number of reposts or public shares •Open and click-through rates on virtual campaigns
Multi-Media Material Development	•Executive committee •Regulatory committees •Advocates •Stakeholders •Site PIS •CRCs	•Publication in scholarly texts •Formal reports to funding agency	•Provide results in a brief, easy-to-read format •Use a mixture of formats •Site teams share findings on their organization's webpages, social media, or other media outlets	•Number of reposts or public shares (physical or electronic) •Open and click-through rates on virtual campaigns •Engagement on social media posts (likes, comments, shares)
Advocacy and Community Group Involvement	•Advocacy partners •Stakeholders •Site PIs •CRCs	Advocacy groups take the initiative to share latest research to patient populations	•Actively elicit input on drafted materials •Advocates advise on content and format of dissemination materials •Identify appropriate dissemination outlets	•Number of reposts or public shares (physical or electronic) •Open and click-through rates on virtual campaigns •Engagement on social media posts (likes, comments, shares)